Norway· NO-ID_FB999F65-02D6-439B-AC9A-81D9F8FD57D3
Cetraxal
A ciprofloxacin product containing ciprofloxacin hydrochloride monohydrate, registered in Norway by POA Pharma Scandinavia AB. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Ciprofloxacin is registered in 10 of 19 countries.
Countries holding a registration under ATC S02AA15 (ciprofloxacin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 5 of them publish a price we can compare per daily dose
Ciprofloxacin · ATC S02AA15
10 / 19 countries
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Ciprofloxacin Hydrochloride Monohydrate
- Manufacturer
- POA Pharma Scandinavia AB
- Country
- Norway (NO)
- ATC code
- S02AA15
- ATC class
- Ciprofloxacin
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_FB999F65-02D6-439B-AC9A-81D9F8FD57D3
- no_varenummer38244915 x 0.25NOK 152.3
- gtin7046263824499
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciprofloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCiprofloxacin OticGenus Lifesciences
- FinlandCetraxalPOA Pharma Scandinavia AB
- IcelandCetraxalPOA Pharma Scandinavia AB
- NetherlandsCetraxal 2 mg/ml oordruppels, oplossingLaboratorios SALVAT, S.A.
- PolandCetraxalTactica Pharmaceuticals Sp. z o.o.
- SwedenCetraxal 2 mg/ml Örondroppar, lösning i endosbehållarePOA Pharma Scandinavia AB
- United KingdomCetraxal 2mg/ml ear drops 0.25ml unit doseAspire Pharma Ltd
- ItalyBASEMARN.I. PHARMA S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ciflox, Ciloxan
- Belgium · Ciloxan, Ciprofloxacine Ab
- Bulgaria · Ciprofloxacin World Medicine Europe Eood, Орпикс
- Cyprus · Cifloxacin, Ciloxan
- Czechia · Cifloxinal, Ciloxan
- Germany · Ciloxan, Cipro
- Denmark · Cetraxal, Cifin
- Estonia · Ciloxan, Ciprinol
- Spain · Aceoto, Cetraflux
- Finland · Cetraxal, Ciprofloxacin Fresenius Kab
- France · Ciflox, Ciloxan
- United Kingdom (Northern Ireland) · Cetraxal, Ciloxan
- Greece · Aristin-C, Bivorilan
- Croatia · Ciflox, Ciloxan
- Hungary · Cifloxin, Cifran
- Ireland · Cifloxager, Cifox
- Iceland · Cetraxal, Ciprofloxacin Alvogen
- Italy · Basemar 250 Mg, Basemar 500 Mg
- Lithuania · Cifran, Ciloxan
- Luxembourg · Ciloxan, Ciprofloxacin Kabi
- Latvia · Cifran, Ciloxan
- Malta · Aristin-C, Cifox
- Netherlands · Cetraxal, Ciprinol
- Poland · Cetraxal, Ciloxan
- Portugal · Cetraflux, Ciplox
- Romania · Cifran, Ciprinol
- Sweden · Cetraxal, Ciloxan
- Slovenia · Ciloxan, Ciprinol
- Slovakia · Ciphin, Ciprinol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed166f55-2767-40a0-b8e5-00bcd7218d91 GET /v1/drugs/ed166f55-2767-40a0-b8e5-00bcd7218d91?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øredråper, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Ciprofloksacin",
"merkevare_id": "ID_FB999F65-02D6-439B-AC9A-81D9F8FD57D3",
"name_form_strength": "Cetraxal øredr, oppl 2 mg/ml",
"prescription_group": "C"
}See everything about ciprofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.